These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1624362)

  • 21. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates.
    Klugman KP; Capper T; Widdowson CA; Koornhof HJ; Moser W
    J Antimicrob Chemother; 1998 Dec; 42(6):729-34. PubMed ID: 10052895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives.
    Qi Y; Jiao B; Ma X; Cui W; Ma S
    Arch Pharm (Weinheim); 2010 Aug; 343(8):458-64. PubMed ID: 20803622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin.
    Novelli A; Fallani S; Cassetta MI; Arrigucci S; Mazzei T
    J Chemother; 2002 Dec; 14(6):584-90. PubMed ID: 12583550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 26. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
    Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates.
    Schouten MA; Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1997 Aug; 40(2):213-9. PubMed ID: 9301986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporeamicin A, a new macrolide antibiotic. II. Structure determination.
    Morishita A; Ishizawa K; Mutoh N; Yamamoto T; Hayashi M; Yaginuma S
    J Antibiot (Tokyo); 1992 May; 45(5):607-12. PubMed ID: 1624361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models.
    Fernandes PB; Swanson RN; Hardy DJ; McDonald EJ; Ramer N
    Drugs Exp Clin Res; 1988; 14(7):441-4. PubMed ID: 2977115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ; Abruzzo GK; Flattery AM; Smith JG; Jackson J; Kong L; Wilkening R; Shankaran K; Kropp H; Bartizal K
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical-physical profile of the novel macrolide antibiotic flurithromycin ethylsuccinate.
    Colombo N; Depaoli A; Gobetti M; Saorin MG
    Arzneimittelforschung; 1994 Jul; 44(7):850-5. PubMed ID: 7945521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
    Girard AE; Cimochowski CR; Faiella JA
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():29-37. PubMed ID: 8396094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new macrolide antibiotic, clarithromycin--synthesis, structure-activity relationship and metabolism].
    Adachi T; Morimoto S
    Seikagaku; 1990 Oct; 62(10):1260-3. PubMed ID: 2150202
    [No Abstract]   [Full Text] [Related]  

  • 35. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
    Kuenzi B; Segessenmann C; Gerber AU
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological properties of 4''-O-acyl derivatives of 8a-Aza-8a-homoerythromycin.
    Stimac V; Alihodzic S; Lazarevski G; Mutak S; Istuk ZM; Fajdetic A; Palej I; Paljetak HC; Marsic N; Padovan J; Tavcar B; Erakovic Haber V
    J Antibiot (Tokyo); 2009 Mar; 62(3):133-44. PubMed ID: 19218983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-Keto-9-O-substituted oxime derivatives of 6-O-methyl erythromycin A synthesis and in vitro activity.
    Shengxi C; Xiandong X; Lanxiang Y
    J Antibiot (Tokyo); 2001 Jun; 54(6):506-9. PubMed ID: 11513040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and in vitro antibacterial activity of 9-O-glycosyloxime derivatives of erythromycin A, a new class of macrolide antibiotics.
    Grandjean C; Lukacs G
    J Antibiot (Tokyo); 1996 Oct; 49(10):1036-43. PubMed ID: 8968398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
    Descheemaeker P; Chapelle S; Lammens C; Hauchecorne M; Wijdooghe M; Vandamme P; Ieven M; Goossens H
    J Antimicrob Chemother; 2000 Feb; 45(2):167-73. PubMed ID: 10660498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.